UPTEMPO
"UPTEMPO" is a word mark owned by Catalent Pharma Solutions, Inc., filed at the UKIPO on May 17, 2023. It is registered and covers classes 1, 5, 40 and 42.
- Status
- Registered
- Since May 17, 2023
- Filed
- May 17, 2023
- Registered
- August 11, 2023
- Expires
- May 17, 2033
- Application no.
- UK00003912507
- Registration no.
- UK00003912507
- Office
- UKIPO
- Intellectual Property Office
- Mark type
- Word mark
- 4 classes
Who owns UPTEMPO
The owner and representative on file with the office.
Owner
Catalent Pharma Solutions, Inc.
United States
Representative
Boult Wade Tennant LLP
Boult Wade Tennant LLP
What the mark covers
The products and services UPTEMPO is filed for, grouped by Nice class.
Cell growth media for growing cells for scientific use; biological preparations for use in industry and science; Cells and cell lines for scientific, laboratory or medical research; Reagents for scientific or medical research use; Biological and biochemical preparations, namely, plasmids, RNA and proteins for scientific, medical research, or research use; Cell culture reagents for scientific and research use; Stem cells for research or scientific purposes; Biological preparations for use in cell cultures other than for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for use in scientific research and analysis.
Cells and cell lines for medical or clinical use; Stem cells for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, DNA plasmids, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations for the treatment of tumours; Cell growth media for growing cells for medical use.
Custom manufacture of biopharmaceuticals; Custom manufacture of pharmaceuticals; Custom manufacture of cells and cell lines for use in viral vector production, and for diagnostic, medical and commercial applications in relation to cell and gene therapies.
Pharmaceutical research and development services; Gene therapy research; Cell therapy research; Scientific research.
About UPTEMPO
Who owns the trademark "UPTEMPO"?
The UKIPO trademark "UPTEMPO" (application UK00003912507) is owned by Catalent Pharma Solutions, Inc.
What is the status of "UPTEMPO"?
Its status at the UKIPO is: registered.
When was "UPTEMPO" registered?
It was registered on August 11, 2023 and is due to expire on May 17, 2033.
Get this data via the API
Everything on this page comes from the Signa API. Pull UPTEMPO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019f4224-aacf-77da-965b-c1464a01c323
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019f4224-aacf-77da-965b-c1464a01c323",
"object": "trademark",
"mark_text": "UPTEMPO",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "GB",
"application_number": "UK00003912507",
"filing_date": "2023-05-17",
"nice_classes": [
1,
5,
40,
42
],
"owners": [
{
"name": "Catalent Pharma Solutions, Inc.",
"entity_id": null
}
]
}